Randomised controlled trials (RCTs) were considered.
do not state how the validity assessment was performed.
Data extraction
Two reviewers independently extracted data from each identified trial onto a standard form, and any disagreements were resolved by a third reviewer.
Methods of synthesis
How were the studies combined? For each comparison within each trial, the absolute difference (in mmol/L) in the mean change in blood total cholesterol values (baseline minus final value) between the intervention and control group was calculated; no distinction was made between serum or plasma cholesterol values. The standard error (SE) for each comparison within each trial was calculated using a given formula; where the values for the standard deviation were not given they were imputed. Similar methods were used to assess changes in the reported dietary intake.
The summary effect for each grouping of different trials was derived from the average of the means of each separate trial, weighted by the reciprocal of SE2 for each trial. For studies with more than one intervention group, the SEs were adjusted to take account of the control group being used more than once. The results were presented as the mean percentage changes in blood total cholesterol concentration, with 95% confidence intervals (CIs). All analyses were performed using the regression techniques available in the statistical software SAS (version 6.07).
How were differences between studies investigated?
Statistical heterogeneity was explored by comparing the observed results in different categories of trials, grouped according to diet, intensity of advice and type of patient. Tests for heterogeneity were performed using the regression techniques available in the statistical software SAS (version 6.07).
Results of the review
Nineteen RCTs (8,550 participants) yielding 28 comparisons were eligible for inclusion in the review; information from one trial was included in 3 publications, whilst another trial included 7 different dietary comparisons.
The overall weighted mean reduction in blood total cholesterol concentration across all dietary comparisons was 5.7% (95% CI: 5.2, 6.3).
From trials of at least 6 months' duration (22 comparisons), the weighted mean reduction in blood total cholesterol concentration across all dietary comparisons was 5.3% (95% CI: 4.7, 5.9). On the assumption that participants lost to follow-up experienced no change, the mean reduction was 4.5% (95% CI: 3.9, 5.1).
The statistical heterogeneity observed in the individual comparisons of more than 6 months was not explained by grouping the trials according to the category of diet.
The differences between the reductions in blood cholesterol concentration observed with the 4 different diets were significant (p<0.001).
From trials of at least 6 months' duration, the reduction in blood total cholesterol concentration found with diet type 1 (n=2,860) was 3.0% (95% CI: 1.8, 4.1), with no significant heterogeneity (p>0.1). The reduction found with diet type 2 (n=2,457) was 5.6% (95% CI: 4.7, 6.5), with significant heterogeneity (p<0.001); this may be explained by the inclusion of the only study in children, which had a smaller effect size. The reduction was 7.6% (95% CI: 6.2, 9.0) for diet type 3 (n=2,163), with significant heterogeneity (p<0.001), and 5.8% (95% CI: 3.8, 7.8) with diet type 4 (n=941), with no significant heterogeneity (p value not given).
Compliance with dietary advice: in general, the dietary targets were not achieved. Among the comparisons of diet type 1, only 2 trials met the targets for both saturated fat and the ratio of polyunsaturated fat to saturated fat; both trials also achieved the largest reductions in blood total cholesterol concentration. Among the comparisons of diet type 2, only one trial met dietary targets. All comparisons of diet type 3 achieved an increase in the ratio of polyunsaturated to saturated
